Torrent Pharma shares rise 6% to 52-week high after Q3 results
after close1 source ↓written by the desknot a recommendation
- for FY26
- ₹3,303 cr
- boosting shares
- 6.05%
- 52-week high
- ₹4,324.90
- increase YoY
- 26.2%
Torrent Pharmaceuticals reported Q3 revenue up 17.6% YoY to ₹3,303 cr for FY26, boosting shares by 6.05% to a 52-week high of ₹4,324.90. The company also declared a net profit of ₹635 cr, a 26.2% increase YoY. This strong performance may enhance investor sentiment in the pharma sector. 💊
Not investment advice. For informational purposes only.